Position in PCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,907,824
+$81,744 QoQ
Shares Held
75,200
-6.9% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. PCRX ranks #24 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,121,700 | $139,643,196 | |
| 2 | ZTS |
Zoetis Inc.
|
1,186,032 | $85,228,259 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
111,255 | $60,281,296 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
268,900 | $45,320,406 | |
| 5 | VTRS |
Viatris Inc
|
2,336,402 | $37,102,063 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,001,992 | $24,659,023 | |
| 7 | ALKS |
Alkermes plc.
|
316,900 | $16,605,560 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
130,654 | $14,494,754 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,907,824 | 75,200 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,826,080 | 80,800 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,179,096 | 84,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,314,146 | 89,800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,112,760 | 88,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,224,075 | 89,500 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,721,976 | 91,400 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,375,570 | 91,400 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,614,954 | 91,400 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,670,708 | 91,400 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,083,836 | 91,400 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,101,748 | 101,100 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,007,000 | 100,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,040,190 | 99,000 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,270,266 | 110,600 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,728,563 | 107,700 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,138,990 | 105,300 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $8,036,496 | 105,300 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,884,626 | 97,800 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,443,200 | 97,200 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $5,813,144 | 95,800 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,609,487 | 94,300 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,493,312 | 91,800 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $5,452,884 | 90,700 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $4,675,077 | 89,100 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,440,984 | 72,800 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||